Cushings syndrome in pregnancy caused by an adrenal adenoma.

OBJECTIVE: The description of a rare case of Cushings syndrome caused by an adrenal adenoma in pregnancy with successful treatment. CASE PRESENTATION: 30-ear-old Gravida 3 female was admitted to our hospital with hypertension at the 18th week of gestation. Hormonal analyses revealed primary Cushings syndrome with high plasma cortisol levels and low levels of adrenocorticotropic hormone. Magnetic resonance imaging demonstrated a mass on the right-side of the adrenal gland. Adrenalectomy was performed in the 28th week of gestation and the following histopathology revealed an adrenocortical adenoma. Pregnancy continued until the 38th week of gestation with glucocorticoid replacement therapy and the patient gave birth vaginally to a healthy boy in the 38th week of gestation. CONCLUSION: Cushings syndrome in pregnancy rarely occurs; dia-gnosis may be dismissed or determined after birth in most cases. Misdia-gnosis of Cushings syndrome is common because of physiological increase of corticotropin hormones and cortisol levels and overlapping symptoms that can occur even during physiological pregnancy. Cushings syndrome should have a place in the differential dia-gnosis of hypertension in pregnancy (especially before the 20th week of gestation). Analysis of the urinary free cortisol level and circadian rhythm blood cortisol can provide a reasonable strategy to dia-gnose Cushings syndrome in pregnant women. Early dia-gnosis and surgical treatment can significantly reduce maternal and fetal complications.

Assessment of phytotoxicity, environmental and health risks of historical urban park soils.

Urban soil areas can be contaminated with potentially dangerous heavy metals (HM), which might have got there by means of the human activity. The aim of the present study was to determine the contamination level of the city park soils and its impact on urban ecosystem. The indices assessing soil contamination such as Enrichment Factor (EF), Geoaccumulation Index (Igeo), Nemerow Pollution Index (IPIN), and indices assessing health risks, namely Hazard Index (HI) and Carcinogenic Risk (CR), have been calculated. Furthermore, the phytotoxic effect of the soil samples has been determined. The soil contains in average 58.6 mg/kg Zn, 0.3 mg/kg Cd, 27.2 mg/kg Pb and 16.6 mg/kg Cu. Based on EF index, it has been confirmed that the increased amounts of Zn, Cd and Pb in the soil are of the anthropogenic origin. The soil may be classified as moderately to strongly polluted in the case of Zn and Pb according to Igeo. Nevertheless, soil contamination in the park is at a safe level as per IPIN. Based on HI and CR indices, it is possible to state that the soil in the park does not pose any health risks. Subject to the outcomes of the toxicity test, the concentrations of HMs found out in the soils are not inhibitory for plants.

Determination of Zinc, Cadmium, Lead, Copper and Silver Using a Carbon Paste Electrode and a Screen Printed Electrode Modified with Chromium(III) Oxide.

In this study, the preparation and electrochemical application of a chromium(III) oxide modified carbon paste electrode (Cr-CPE) and a screen printed electrode (SPE), made from the same material and optimized for the simple, cheap and sensitive simultaneous determination of zinc, cadmium, lead, copper and the detection of silver ions, is described. The limits of detection and quantification were 25 and 80 µg·L-1 for Zn(II), 3 and 10 µg·L-1 for Cd(II), 3 and 10 µg·L-1 for Pb(II), 3 and 10 µg·L-1 for Cu(II), and 3 and 10 µg·L-1 for Ag(I), respectively. Furthermore, this promising modification was transferred to the screen-printed electrode. The limits of detection for the simultaneous determination of zinc, cadmium, copper and lead on the screen printed electrodes were found to be 350 µg·L-1 for Zn(II), 25 µg·L-1 for Cd(II), 3 µg·L-1 for Pb(II) and 3 µg·L-1 for Cu(II). Practical usability for the simultaneous detection of these heavy metal ions by the Cr-CPE was also demonstrated in the analyses of wastewaters.

Site-Directed Conjugation of Antibodies to Apoferritin Nanocarrier for Targeted Drug Delivery to Prostate Cancer Cells.

Herein, we describe a novel approach for targeting of ubiquitous protein apoferritin (APO)-encapsulating doxorubicin (DOX) to prostate cancer using antibodies against prostate-specific membrane antigen (PSMA). The conjugation of anti-PSMA antibodies and APO was carried out using HWRGWVC heptapeptide, providing their site-directed orientation. The prostate-cancer-targeted and nontargeted nanocarriers were tested using LNCaP and HUVEC cell lines. A total of 90% of LNCaP cells died after treatment with DOX (0.25 µM) or DOX in nontargeted and prostate-cancer-targeted APO, proving that the encapsulated DOX toxicity for LNCaP cells remained the same. Free DOX showed higher toxicity for nonmalignant cells, whereas the toxicity was lower after treatment with the same dosage of APO-encapsulated DOX (APODOX) and even more in prostate-cancer-targeted APODOX. Hemolytic assay revealed exceptional hemocompatibility of the entire nanocarrier. The APO encapsulation mechanism ensures applicability using a wide variety of chemotherapeutic drugs, and the presented surface modification enables targeting to various tumors.